Page 32 - 南京医科大学学报自然科学版
P. 32

第43卷第1期
               · 26  ·                           南 京    医 科 大 学 学         报                        2023年1月


                   mesenchymal transition and cancer stem cell interactions  Clin Oncol,2019,145(4):909-919
                   in breast phyllodes tumours:immunohistochemical evalu⁃  [23] ZHOU Q,SUN X,PASQUIER N,et al. Cell⁃penetrating
                   ation of EZH2,EZR,HMGA2,CD24 and CD44 in corre⁃   CEBPB and CEBPD leucine zipper decoys as broadly act⁃
                   lation with outcome analysis[J]. J Clin Pathol,2022,75  ing anti ⁃ cancer agents[J]. Cancers(Basel),2021,13
                  (5):316-323                                       (10):2504
             [18] YU L,LEMAY P,LUDLOW A,et al. A new murine Rpl5  [24] SUN X,JEFFERSON P,ZHOU Q,et al. Dominant⁃nega⁃
                  (uL18)mutation provides a unique model of variably pen⁃  tive ATF5 compromises cancer cell survival by targeting
                   etrant Diamond⁃Blackfan anemia[J]. Blood Adv,2021,5  CEBPB and CEBPD[J]. Mol Cancer Res,2020,18(2):
                  (20):4167-4178                                     216-228
             [19] LIU N,WU Z,CHEN A,et al. SNRPB promotes the tu⁃  [25] WANG F,GAO Y,TANG L,et al. A novel PAK4⁃CEBPB⁃
                   morigenic potential of NSCLC in part by regulating  CLDN4 axis involving in breast cancer cell migration and
                   RAB26[J]. Cell Death Dis,2019,10(9):667           invasion[J]. Biochem Biophys Res Commun,2019,511
             [20] YANG H,MAO W,RODRIGUEZ⁃AGUAYO C,et al. Pa⁃        (2):404-408
                   clitaxel sensitivity of ovarian cancer can be enhanced by  [26] LU J,CHEN W,LIU H,et al. Transcription factor CEBPB
                   knocking down pairs of kinases that regulate MAP4 phos⁃  inhibits the proliferation of osteosarcoma by regulating
                   phorylation and microtubule stability[J]. Clin Cancer  downstream target gene CLEC5A[J]. J Clin Lab Anal,
                   Res,2018,24(20):5072-5084                         2019,33(9):e22985
             [21] YANG H,MAO W,RODRIGUEZ⁃AGUAYO C,et al. Cor⁃   [27] GUERZONI C,BARDINI M,MARIANI S A,et al. Induc⁃
                   rection:paclitaxel sensitivity of ovarian cancer can be en⁃  ible activation of CEBPB,a gene negatively regulated by
                   hanced by knocking down pairs of kinases that regulate  BCR/ABL,inhibits proliferation and promotes differentia⁃
                   MAP4 phosphorylation and microtubule stability[J]. Clin  tion of BCR/ABL⁃expressing cells[J]. Blood,2006,107
                   Cancer Res,2020,26(18):5050                      (10):4080-4089
             [22] ZHANG S,DEEN S,STORR S J,et al. Expression of Syk                       [收稿日期] 2022-04-11
                   and MAP4 proteins in ovarian cancer[J]. J Cancer Res                        (责任编辑:蒋      莉)

















                     

                                 欢迎投稿 欢迎订阅






                                                                                                         
                                                                                                         
   27   28   29   30   31   32   33   34   35   36   37